市場調査レポート

商品コード

酵素補充療法市場の2028年までの予測-酵素タイプ、治療条件、投与経路、エンドユーザー別の世界分析

Enzyme Replacement Therapy Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Enzyme Type, Therapeutic Conditions, Route of Administration, and End User

出版日: 2022年07月18日 | 発行: The Insight Partners

| ページ情報: 英文 226 Pages | 納期: 即納可能

価格

PDF (Single User License)

USD 4,550 712,439円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は一度のみ可能です。印刷したもののご利用はPDFのライセンス保持者に限定されます。

PDF (Site License)

USD 6,550 1,025,599円

レポートPDFを同一事業所（所在地）内のすべての方にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise License)

USD 8,550 1,338,759円

レポートPDFを企業内すべての方に使用頂けるライセンスです。PDF内のテキスト等のコピーは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.58円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

酵素補充療法市場は、2021年の96億7,339万米ドルから2028年には151億8,470万米ドルに成長すると予測され、2022年から2028年までのCAGRは6.8%と推定されています。

本レポートでは、市場に蔓延する動向と市場成長を促進する要因について取り上げています。酵素補充療法の世界市場の成長は、ライソゾーム蓄積疾患（LSD）の有病率の上昇と、オーファン薬に指定された薬剤の迅速な規制承認とその他のマーケティング上の利点に起因しています。しかし、市場参加者間の熾烈な競争が市場全体の成長を妨げています。

酵素補充療法（ERT）は、酵素活性を有する酵素またはタンパク質を用いて、先天性酵素欠乏症を治療するために行われるものです。治療に必要な酵素の供給源としては、動物性、ヒト性、組換え工学的なものがあります。一般に、ポンペ病、ファブリー病、ゴーシェ病、テイサックス病、ハーラー症候群などの希少疾患やライソゾーム貯蔵疾患に適用されています。ERTの最も一般的な方法は、点滴によって補酵素を血液中に直接投与する方法です。

オーファンドラッグの承認は欧州医薬品庁（EMA）が行っています。例えば、EMAによると、オーファンドラッグの指定を受けた製品が、その指定を受けた適応症でEMAの販売承認を受けた場合、その製品はオーファン市場独占権を得ることができます。つまり、EMAは10年間、同じ適応症に対する他の類似薬の販売申請を承認することができないのです。

さらに、2016年3月、EMAは、現在治療法がほとんど存在しない、あるいは存在しない、しばしば希少な適応症の製品候補の開発を促進するために、優先医薬品（「PRIME」）制度を発足させました。PRIME制度は、医薬品候補がPRIMEに選定されると、医薬品メーカーにいくつかのメリットを提供します。以下は、EMAが提供するメリットです。

ヒト用医薬品委員会（CHMP）から報告者を任命し、製造販売承認申請に向けた知識の蓄積をサポート

EMAとの早期かつ積極的な規制当局との対話により、全体的な開発計画および規制戦略を導く。

患者さんの新薬への迅速なアクセスを促進するため、医療技術評価機関などの利害関係者を巻き込み、開発の主要な節目で科学的助言を提供します。

製造販売承認申請時の早期審査の可能性を確認します。

このように、オーファンドラッグに指定された医薬品には恩恵とインセンティブがあるため、市場で活動する主要企業はオーファンドラッグの開発に力を注いでいます。例えば、Amicus Therapeutics, Inc.は、ファブリー病を治療するGalafoldとポンペ病を治療するATB200/AT2221の組み合わせについて、最近EMAから欧州におけるオーファン医薬品の指定を受けています。さらに、2020年9月には、アミカス・セラピューティクス社がCLN6バッテン病の治療薬、AT-GTX-501のPRIME指定を受けています。

このように、オーファンドラッグ指定の薬剤の他のマーケティング上の利点を伴う迅速な規制当局の承認は、市場の成長を促進しています。

酵素の種類に基づき、世界の酵素補充療法市場は、アルグルコシダーゼ・アルファ、アガルシダーゼ・ベータ、イミグルセラーゼ、イドゥルスルファーゼ、ガルサルファーゼ、ベラグルセラーゼ・アルファ、およびその他の酵素に区分されます。2021年では、その他の酵素セグメントが最大の市場シェアを占めています。同セグメントは、2022年から2028年にかけて、市場で最も高いCAGRを記録すると予想されます。酵素補充療法の世界市場は、治療状態に基づいて、ゴーシェ病、ファブリー病、ポンペ病、SCID、MPS、およびその他の治療状態に区分されます。ゴーシェ病セグメントは2021年に最大の市場シェアを占め、予測期間中に最も高いCAGRを記録すると予想されます。投与経路に基づき、世界の酵素補充療法市場は非経口と経口に二分化されます。2021年には非経口セグメントがより大きな市場シェアを占め、予測期間中はより高いCAGRを記録すると予測されています。エンドユーザーに基づいて、世界の酵素補充療法市場は、病院、輸液センター、およびその他に区分されます。2021年には、病院セグメントが最大の市場シェアを占めています。しかし、輸液センターセグメントは、予測期間中に最も高いCAGRを記録すると予想されます。

COVID-19パンデミックが酵素補充療法の世界市場に与える影響

COVID-19のパンデミックは、世界のヘルスケアシステムに大きな影響を与えました。SAR-CoV-2ウイルスの蔓延に対抗するため、各国政府は感染と死亡率を予防・低減するための厳格な政策を実施しました。救急医学科によると、北米の様々な国の多くの都市で、2020年に救急部（ED）訪問が～40％減少しました。さらに、外来患者の予約や選択的治療が延期されたり、遠隔医療行為に置き換えられたりしました。

さらに、COVID-19のパンデミック時のERTの中断は重大な結果をもたらす可能性があります。パンデミック時の通院制限のため、予定されていたERTの多くが中断され、その結果、LSDs患者の病状が重篤化したのです。また、ライソゾーム貯蔵病は呼吸器、腎臓、心臓の病変があるため、リスクが高いとされています。例えば、2021年にインドのSir Ganga Ram病院の一部の医師が行ったサンプル調査、その結果はIndian Pediatricsに掲載され、危機感を垣間見ることができました。この調査では、ライソゾーム蓄積障害を患い、同病院でERTを受けている患者26人のうち、20人（77％）が治療を大幅に中断し、平均8回の服用を見合わせたことが判明しました。複数回投与できなかった20人のうち、13人（65％）は、ロックダウンが実施されていたため交通手段がなく、三次医療機関から薬を受け取ることができず、2人（10％）は、薬の輸入が遅れたためでした。このように、ERTの中断はLSD患者の苦痛を増大させ、酵素補充療法市場にマイナスの影響を与えました。

世界の酵素補充療法市場で活動する企業は、さまざまな有機的および無機的戦略を採用しています。有機的戦略には、主に製品の上市と製品承認が含まれます。さらに、市場で示された無機的な成長戦略は、買収、共同研究、およびパートナーシップです。これらの成長戦略により、市場参加者は事業を拡大し、地理的プレゼンスを高めることができ、それによって市場全体の成長に貢献することができます。さらに、買収とパートナーシップ戦略は、顧客基盤を強化し、製品ポートフォリオを拡大する上で、市場プレイヤーを支援します。世界の酵素補充療法市場における主要企業の重要な発展のいくつかを以下に示します。

2022年5月、アッヴィと、自己免疫疾患および癌を治療するための次世代精密免疫学および癌治療薬の開発に注力する臨床段階のバイオテクノロジー企業であるCugene Inc.は、ベストインクラスのTreg選択的IL-2ムテインとなり得るCUG252、およびその他の新規IL-2ムテインについて自己免疫疾患および炎症疾患の治療のための世界的独占ライセンスオプション契約を締結したと発表しました。

2021年8月、米国食品医薬品局（FDA）は、進行性の衰弱性筋疾患であり、人の運動能力や呼吸能力が損なわれる晩発性ポンペ病の1歳以上の患者を対象に、ネクスビアザイム（アバルグルコシダーゼ・アルファ-NGP）を承認しました。ネクスビアザイムは、ポンペ病におけるERTの細胞内取り込み経路であるマンノース6リン酸（M6P）受容体を特異的に標的としたERTです。Nexviazymeは、臨床試験において、患者に呼吸機能と歩行距離の改善をもたらすことが示されています。

世界の酵素補充療法市場に関するレポート作成時に参照した主な一次情報および二次情報は、National Health and Medical Research Council（NHMRC）、カナダ政府、Bioprocessing Technology Institute（BTI）などがあります。

調査対象範囲
インサイトパートナーズの調査報告書ガイダンス
市場セグメンテーション
- 酵素補充療法の世界市場- 酵素タイプ別
- 酵素補充療法の世界市場-治療条件別
- 酵素補充療法の世界市場-投与経路別
- 酵素補充療法の世界市場-エンドユーザー別
- 酵素補充療法の世界市場-地域別

第2章酵素補充療法市場-主要なポイント

第3章調査手法

調査対象
2次調査
1次調査

第4章酵素補充療法の世界市場-市場情勢

PEST分析
- 北米-PEST分析
- 欧州-PEST分析
- アジア太平洋-PEST分析
- 中東・アフリカのPEST分析
- 中南米-PEST分析
専門家の見解

第5章酵素補充療法市場- 主な市場力学

市場促進要因
- ライソゾーム蓄積性疾患（LSD）の有病率の上昇
- 希少疾病用医薬品の指定別迅速な承認とその他の利点
市場抑制要因
- 市場プレイヤー間の熾烈な競争
市場機会
- 事業シナジーのためのパートナーシップとコラボレーションの増加
今後の動向
- ERTの革新的な開発
インパクト分析

第6章酵素補充療法市場-世界分析

酵素補充療法の世界市場収益と予測・分析
- 酵素補充療法の世界市場収益予測と分析
- 酵素補充療法の世界市場-地域別市場ポテンシャル分析
酵素補充療法市場における主要企業の市場シェア分析
- 企業分析
- 成長戦略分析
- 主要プレイヤーの業績
  - サノフィS.A.
  - バイオマリン・ファーマシューティカル・インク

第7章酵素補充療法の世界市場収益と2028年までの予測-酵素タイプ別

酵素補充療法の世界市場、酵素タイプ別2021年・2028年（%）
アルグルコシダーゼ・アルファ
アガルシダーゼベータ
イミグルコシダーゼ
イドゥルスルファ-ゼ
ガルスルファーゼ
ベラグルセラーゼ・アルファ
その他の酵素

第8章酵素補充療法市場の分析と2028年までの予測-治療条件別

酵素補充療法の世界市場：治療条件別2021年・2028年（%）
ゴーシェ病
ファブリー病
ムコ多糖症（MPS）
ポンペ病
SCID
その他の治療条件

第9章酵素補充療法市場の分析と2028年までの予測-投与経路別

酵素補充療法の世界市場：投与ルート別2021年・2028年（%）
非経口
経口

第10章酵素補充療法の世界市場分析-エンドユーザー別

酵素補充療法の世界市場：エンドユーザー別2021 &2028（%）
病院
輸液センター
その他

第11章酵素補充療法市場の収益と2028年までの予測- 地域別分析

北米
- 米国
- カナダ
- メキシコ
欧州
- ドイツ
- 英国
- フランス
- イタリア
- スペイン
- その他欧州
アジア太平洋地域
- 日本
- 中国
- インド
- オーストラリア
- 韓国
- その他アジア太平洋地域
中南米地域
- 中南米地域
  - ブラジル
  - アルゼンチン
  - その他の中南米地域
中東・アフリカ
- サウジアラビア
- 南アフリカ
- UAE
- その他中東・アフリカ地域

第12章酵素補充療法市場へのCOVID-19パンデミックの影響

北米
欧州
アジア太平洋地域
中南米
中東とアフリカ

第13章酵素補充療法市場-業界情勢

酵素補充療法市場の成長戦略
無機的な成長戦略
有機的成長戦略

第14章企業プロファイル

Takeda Pharmaceutical Company Limited
Sanofi
AbbVie Inc.
BioMarin Pharmaceutical Inc.
Amicus Therapeutics
Alexion Pharmaceuticals, Inc.（AstraZeneca）
Janssen Pharmaceuticals（Johnson & Johnson Services, Inc.）
Recordati S.p.A.
Pfizer Inc.
CHIESI Farmaceutici S.p.A.

第15章付録

インサイト・パートナーズについて
用語解説

図表

List Of Tables

Table 1. North America Enzyme Replacement Therapy Market, by Enzyme Type - Revenue and Forecast to 2028 (US$ Million)
Table 2. North America Enzyme Replacement Therapy Market, by Therapeutic Conditions - Revenue and Forecast to 2028 (USD Million)
Table 3. North America Enzyme Replacement Therapy Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
Table 4. North America Enzyme Replacement Therapy Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 5. US: Enzyme Replacement Therapy Market, by Enzyme Type - Revenue and Forecast to 2028 (US$ Million)
Table 6. US Enzyme Replacement Therapy Market, by Therapeutic Conditions - Revenue and Forecast to 2028 (USD Million)
Table 7. US Enzyme Replacement Therapy Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
Table 8. US Enzyme Replacement Therapy Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 9. Canada Enzyme Replacement Therapy Market, by Enzyme Type - Revenue and Forecast to 2028 (US$ Million)
Table 10. Canada Enzyme Replacement Therapy Market, by Therapeutic Conditions - Revenue and Forecast to 2028 (USD Million)
Table 11. Canada Enzyme Replacement Therapy Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
Table 12. Canada Enzyme Replacement Therapy Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 13. Mexico Enzyme Replacement Therapy Market, by Enzyme Type - Revenue and Forecast to 2028 (US$ Million)
Table 14. Mexico Enzyme Replacement Therapy Market, by Therapeutic Conditions - Revenue and Forecast to 2028 (USD Million)
Table 15. Mexico Enzyme Replacement Therapy Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
Table 16. Mexico Enzyme Replacement Therapy Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 17. Europe Enzyme Replacement Therapy Market, by Enzyme Type - Revenue and Forecast to 2028 (US$ Million)
Table 18. Europe Enzyme Replacement Therapy Market, by Therapeutic Conditions - Revenue and Forecast to 2028 (USD Million)
Table 19. Europe Enzyme Replacement Therapy Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
Table 20. Europe Enzyme Replacement Therapy Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 21. Germany Enzyme Replacement Therapy Market, by Enzyme Type - Revenue and Forecast to 2028 (US$ Million)
Table 22. Germany Enzyme Replacement Therapy Market, by Therapeutic Conditions - Revenue and Forecast to 2028 (USD Million)
Table 23. Germany Enzyme Replacement Therapy Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
Table 24. Germany Enzyme Replacement Therapy Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 25. UK Enzyme Replacement Therapy Market, by Enzyme Type - Revenue and Forecast to 2028 (US$ Million)
Table 26. UK Enzyme Replacement Therapy Market, by Therapeutic Conditions - Revenue and Forecast to 2028 (USD Million)
Table 27. UK Enzyme Replacement Therapy Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
Table 28. UK Enzyme Replacement Therapy Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 29. France Enzyme Replacement Therapy Market, by Enzyme Type - Revenue and Forecast to 2028 (US$ Million)
Table 30. France Enzyme Replacement Therapy Market, by Therapeutic Conditions - Revenue and Forecast to 2028 (USD Million)
Table 31. France Enzyme Replacement Therapy Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
Table 32. France Enzyme Replacement Therapy Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 33. Italy Enzyme Replacement Therapy Market, by Enzyme Type - Revenue and Forecast to 2028 (US$ Million)
Table 34. Italy Enzyme Replacement Therapy Market, by Therapeutic Conditions - Revenue and Forecast to 2028 (USD Million)
Table 35. Italy Enzyme Replacement Therapy Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
Table 36. Italy Enzyme Replacement Therapy Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 37. Spain Enzyme Replacement Therapy Market, by Enzyme Type - Revenue and Forecast to 2028 (US$ Million)
Table 38. Spain Enzyme Replacement Therapy Market, by Therapeutic Conditions - Revenue and Forecast to 2028 (USD Million)
Table 39. Spain Enzyme Replacement Therapy Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
Table 40. Spain Enzyme Replacement Therapy Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 41. Rest of Europe Enzyme Replacement Therapy Market, by Enzyme Type - Revenue and Forecast to 2028 (US$ Million)
Table 42. Rest of Europe Enzyme Replacement Therapy Market, by Therapeutic Conditions - Revenue and Forecast to 2028 (USD Million)
Table 43. Rest of Europe Enzyme Replacement Therapy Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
Table 44. Rest of Europe Enzyme Replacement Therapy Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 45. Asia Pacific: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Enzyme Type (US$ Million).
Table 46. Asia Pacific: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Therapeutic Conditions (US$ Million)
Table 47. Asia Pacific: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
Table 48. Asia Pacific: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 49. Japan: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Enzyme Type (US$ Million)
Table 50. Japan: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Therapeutic Conditions (US$ Million)
Table 51. Japan: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
Table 52. Japan: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 53. China: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Enzyme Type (US$ Million)
Table 54. China: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Therapeutic Conditions (US$ Million)
Table 55. China: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
Table 56. China: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 57. India: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Enzyme Type (US$ Million)
Table 58. India: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Therapeutic Conditions (US$ Million)
Table 59. India: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
Table 60. India: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 61. Australia: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Enzyme Type (US$ Million)
Table 62. Australia: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Therapeutic Conditions (US$ Million)
Table 63. Australia: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
Table 64. Australia: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 65. South Korea: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Enzyme Type (US$ Million)
Table 66. South Korea: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Therapeutic Conditions (US$ Million)
Table 67. South Korea: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
Table 68. South Korea: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 69. Rest of Asia Pacific: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Enzyme Type (US$ Million)
Table 70. Rest of Asia Pacific: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Therapeutic Conditions (US$ Million)
Table 71. Rest of Asia Pacific: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
Table 72. Rest of Asia Pacific: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 73. South and Central America: Enzyme Replacement Therapy Market, by Enzyme Type - Revenue and Forecast to 2028 (USD Million)
Table 74. South and Central America: Enzyme Replacement Therapy Market, by Therapeutic Conditions - Revenue and Forecast to 2028 (USD Million)
Table 75. South and Central America: Enzyme Replacement Therapy Market, by Route of Administration- Revenue and Forecast to 2028 (USD Million)
Table 76. South and Central America: Enzyme Replacement Therapy Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 77. Brazil: Enzyme Replacement Therapy Market, by Enzyme Type - Revenue and Forecast to 2028 (USD Million)
Table 78. Brazil: Enzyme Replacement Therapy Market, by Therapeutic Conditions - Revenue and Forecast to 2028 (USD Million)
Table 79. Brazil: Enzyme Replacement Therapy Market, by Route of Administration- Revenue and Forecast to 2028 (USD Million)
Table 80. Brazil: Enzyme Replacement Therapy Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 81. Argentina: Enzyme Replacement Therapy Market, by Enzyme Type - Revenue and Forecast to 2028 (USD Million)
Table 82. Argentina: Enzyme Replacement Therapy Market, by Therapeutic Conditions - Revenue and Forecast to 2028 (USD Million)
Table 83. Argentina: Enzyme Replacement Therapy Market, by Route of Administration- Revenue and Forecast to 2028 (USD Million)
Table 84. Argentina: Enzyme Replacement Therapy Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 85. Rest of South and Central America: Enzyme Replacement Therapy Market, by Enzyme Type - Revenue and Forecast to 2028 (USD Million)
Table 86. Rest of South and Central America: Enzyme Replacement Therapy Market, by Therapeutic Conditions - Revenue and Forecast to 2028 (USD Million)
Table 87. Rest of South and Central America: Enzyme Replacement Therapy Market, by Route of Administration- Revenue and Forecast to 2028 (USD Million)
Table 88. Rest of South and Central America: Enzyme Replacement Therapy Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 89. Middle East & Africa: Enzyme Replacement Therapy Market Revenue and Forecast to 2028, by Enzyme Type (US$ Million)
Table 90. Middle East & Africa: Enzyme Replacement Therapy Market Revenue and Forecast to 2028, by Therapeutic Conditions (US$ Million)
Table 91. Middle East & Africa: Enzyme Replacement Therapy Market Revenue and Forecast to 2028, by Route of Administration (US$ Million)
Table 92. Middle East & Africa: Enzyme Replacement Therapy Market Revenue and Forecast to 2028, by End User (US$ Million)
Table 93. Saudi Arabia: Enzyme Replacement Therapy Market Revenue and Forecast to 2028, By Enzyme Type (US$ Million)
Table 94. Saudi Arabia: Enzyme Replacement Therapy Market Revenue and Forecast to 2028, By Therapeutic Conditions (US$ Million)
Table 95. Saudi Arabia: Enzyme Replacement Therapy Market Revenue and Forecast to 2028, By Route of Administration (US$ Million)
Table 96. Saudi Arabia: Enzyme Replacement Therapy Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 97. South Africa: Enzyme Replacement Therapy Market Revenue and Forecast to 2028, By Enzyme Type (US$ Million)
Table 98. South Africa: Enzyme Replacement Therapy Market Revenue and Forecast to 2028, By Therapeutic Conditions (US$ Million)
Table 99. South Africa: Enzyme Replacement Therapy Market Revenue and Forecast to 2028, By Route of Administration (US$ Million)
Table 100. South Africa: Enzyme Replacement Therapy Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 101. UAE: Enzyme Replacement Therapy Market Revenue and Forecast to 2028, By Enzyme Type (US$ Million)
Table 102. UAE: Enzyme Replacement Therapy Market Revenue and Forecast to 2028, By Therapeutic Conditions (US$ Million)
Table 103. UAE: Enzyme Replacement Therapy Market Revenue and Forecast to 2028, By Route of Administration (US$ Million)
Table 104. UAE: Enzyme Replacement Therapy Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 105. Rest of the Middle East and Africa: Enzyme Replacement Therapy Market Revenue and Forecast to 2028, By Enzyme Type (US$ Million)
Table 106. Rest of the Middle East and Africa: Enzyme Replacement Therapy Market Revenue and Forecast to 2028, By Therapeutic Conditions (US$ Million)
Table 107. Rest of the Middle East and Africa: Enzyme Replacement Therapy Market Revenue and Forecast to 2028, By Route of Administration (US$ Million)
Table 108. Rest of the Middle East and Africa: Enzyme Replacement Therapy Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 109. Recent Inorganic Growth Strategies in the Enzyme Replacement Therapy Market
Table 110. Recent Organic Growth Strategies in the Enzyme Replacement Therapy Market
Table 111. Glossary of Terms

List Of Figures

Figure 1. Enzyme Replacement Therapy Market Segmentation
Figure 2. Enzyme Replacement Therapy Market Segmentation, By Region
Figure 3. Global Enzyme Replacement Therapy Market Overview
Figure 4. Others Enzyme Segment Held Largest Share by Enzyme Type in Enzyme Replacement Therapy Market
Figure 5. Asia-Pacific Region Is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Global Enzyme Replacement Therapy Market, By Geography (US$ Million)
Figure 7. Global Enzyme Replacement Therapy Market - Leading Country Markets (US$ Million)
Figure 8. Global Enzyme Replacement Therapy Market, Industry Landscape
Figure 9. North America: PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. Asia Pacific: PEST Analysis
Figure 12. Middle East & Africa: PEST Analysis
Figure 13. South & Central America: PEST Analysis
Figure 14. Impact Analysis
Figure 15. Global Enzyme Replacement Therapy Market- Revenue Forecast and Analysis - 2020- 2028
Figure 16. Global Enzyme Replacement Therapy Market- Revenue Forecast And Analysis - 2021 - 2028
Figure 17. Global Enzyme Replacement Therapy Market - Market Potential Analysis, By Region
Figure 18. Market Share Analysis of Key Players in Global Enzyme Replacement Therapy Market
Figure 19. Global Enzyme Replacement Therapy Market - Comparative Company Analysis
Figure 20. Global Enzyme Replacement Therapy Market - Growth Strategy Analysis
Figure 21. Market positioning of Key Players in Enzyme Replacement Therapy Market
Figure 22. Global Enzyme Replacement Therapy Market, by Enzyme Type 2021 & 2028 (%)
Figure 23. Alglucosidase Alfa Revenue and Forecasts to 2028 (US$ Million)
Figure 24. Agalsidase Beta - Revenue and Forecasts to 2028 (US$ Million)
Figure 25. Imiglucerase - Revenue and Forecasts to 2028 (US$ Million)
Figure 26. Idursulfase - Revenue and Forecasts to 2028 (US$ Million)
Figure 27. Galsulfase - Revenue and Forecasts to 2028 (US$ Million)
Figure 28. Velaglucerase Alfa - Revenue and Forecasts to 2028 (US$ Million)
Figure 29. Other Enzymes - Revenue and Forecasts to 2028 (US$ Million)
Figure 30. Global Enzyme Replacement Therapy Market, by Therapeutic Conditions 2021 & 2028 (%)
Figure 31. Gaucher's Disease - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 32. Fabry's Disease - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 33. MPS - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 34. Pompe's Disease - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 35. SCID - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 36. Other Therapeutic Conditions - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 37. Global Enzyme Replacement Therapy Market, by Route of Administration 2021 & 2028 (%)
Figure 38. Parenteral - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 39. Oral - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 40. Global Enzyme Replacement Therapy Market, by End User 2021 & 2028 (%)
Figure 41. Hospitals - Market Revenue And Forecasts To 2028 (US$ Million)
Figure 42. Infusion Centers - Market Revenue And Forecasts To 2028 (US$ Million)
Figure 43. Others- Market Revenue And Forecasts To 2028 (US$ Million)
Figure 44. North America: Enzyme Replacement Therapy Market, by Key Country - Revenue (2021) (US$ Million)
Figure 45. North America Enzyme Replacement Therapy Market Revenue and Forecast to 2028 (US$ Million)
Figure 46. North America: Enzyme Replacement Therapy Market, by Country, 2021 & 2028 (%)
Figure 47. US: Enzyme Replacement Therapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 48. Canada: Enzyme Replacement Therapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 49. Mexico: Enzyme Replacement Therapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 50. Europe: Enzyme Replacement Therapy Market, by Key Country - Revenue (2021) (US$ Million)
Figure 51. Europe: Enzyme Replacement Therapy Market Revenue and Forecast to 2028 (US$ Million)
Figure 52. Europe: Enzyme Replacement Therapy Market, by Country, 2021 & 2028 (%)
Figure 53. Germany: Enzyme Replacement Therapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 54. UK: Enzyme Replacement Therapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 55. France: Enzyme Replacement Therapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 56. Italy: Enzyme Replacement Therapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 57. Spain: Enzyme Replacement Therapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 58. Rest of Europe: Enzyme Replacement Therapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 59. Asia Pacific: Enzyme Replacement Therapy Market Overview, by Country (2021)
Figure 60. Asia Pacific: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028 (US$ Million)
Figure 61. Asia Pacific: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Country (%)
Figure 62. Japan: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028 (US$ Million)
Figure 63. China: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028 (US$ Million)
Figure 64. India: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028 (US$ Million)
Figure 65. Australia: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028 (US$ Million)
Figure 66. South Korea: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028 (US$ Million)
Figure 67. Rest of Asia Pacific: Enzyme Replacement Therapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 68. South and Central America: Enzyme Replacement Therapy Market, by Key Country - Revenue (2021) (US$' Million)
Figure 69. South and Central America Enzyme Replacement Therapy Market Revenue and Forecast to 2028 (USD Million)
Figure 70. South and Central America: Enzyme Replacement Therapy Market, by country, 2021 & 2028 (%)
Figure 71. Brazil: Enzyme Replacement Therapy Market - Revenue and Forecast to 2028 (USD Million)
Figure 72. Argentina: Enzyme Replacement Therapy Market - Revenue and Forecast to 2028 (USD Million)
Figure 73. Rest of South and Central America: Enzyme Replacement Therapy Market - Revenue and Forecast to 2028 (USD Million)
Figure 74. Middle East & Africa Enzyme Replacement Therapy Market Revenue Overview, by Country, 2021 (US$ Million)
Figure 75. Middle East & Africa Enzyme: Replacement Therapy Market Revenue and Forecast to 2028 (US$ Million)
Figure 76. Middle East & Africa Enzyme Replacement Therapy Market Revenue and Forecast to 2028, by Country (%)
Figure 77. Saudi Arabia: Enzyme Replacement Therapy Market Revenue and Forecast to 2028 (US$ Million)
Figure 78. South Africa: Enzyme Replacement Therapy Market Revenue and Forecast to 2028 (US$ Million)
Figure 79. UAE: Enzyme Replacement Therapy Market Revenue and Forecast to 2028 (US$ Million)
Figure 80. Rest of the Middle East and Africa: Enzyme Replacement Therapy Market Revenue and Forecast to 2028 (US$ Million)
Figure 81. Impact of COVID-19 Pandemic in North American Country Markets
Figure 82. Impact of COVID-19 Pandemic in European Country Markets
Figure 83. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 84. Impact of COVID-19 Pandemic in South and Central American Countries
Figure 85. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets
Figure 86. Growth Strategies in the Enzyme Replacement Therapy Market

Product Code: TIPRE00008474

The enzyme replacement therapy market is expected to grow from US$ 9,673.39 million in 2021 to US$ 15,184.70 million by 2028; it is estimated to grow at a CAGR of 6.8% from 2022 to 2028.

The report highlights trends prevailing in the market and factors driving the market growth. The growth of the global enzyme replacement therapy market is attributed to the rising prevalence of lysosomal storage diseases (LSDs) and rapid regulatory approval with other marketing benefits for drug with orphan drug designation. However, cutthroat competition among market players hinders the overall market growth.

Enzyme replacement therapy (ERT) is performed to treat congenital enzyme deficiencies by using enzyme or protein having enzymatic activity. Animal, human, and recombinant engineered enzymes are a few sources of enzyme required for treatment. The therapy is generally applied in rare and lysosomal storage diseases, including Pompe's disease, Fabry's disease, Gaucher's disease, Tay-Sachs disease, and Hurler syndrome. The most common ERT method is IV infusions, in which the replacement enzyme is administered directly into the bloodstream through a controlled drip of fluids.

European Medicines Agency (EMA) approves orphan drugs. For instance, according to EMA, if a product that has an orphan drug designation receives EMA marketing approval for the indication for which it has such designation, the product is entitled to orphan market exclusivity. It means the EMA may not approve any other application to market a similar drug for the same indication for 10 years.

Furthermore, in March 2016, the EMA launched the Priority Medicines ("PRIME") scheme to facilitate the development of product candidates in indications, often rare, for which few or no therapies currently exist. The PRIME scheme also provides several benefits to drug producers; once a candidate medicine is selected for PRIME. Below mentioned are the benefits provided by the EMA:

Appoint a rapporteur from the Committee for Medicinal Products for Human Use (CHMP) and help to build knowledge ahead of a marketing-authorization application

Early and proactive regulatory dialogue with the EMA to guide the overall development plan and regulatory strategy;

Provide scientific advice at key development milestones, involving additional stakeholders such as health-technology-assessment bodies, to facilitate quicker access for patients to the new medicine;

Confirm potential for accelerated assessment at the time of an application for marketing authorization.

Therefore, owing to the benefit and incentives associated with drugs designated as orphan drugs, key players operating in the market are putting efforts into developing drugs for orphan diseases. For instance, Amicus Therapeutics, Inc. recently obtained an orphan medicinal product designation in Europe from the EMA for Galafold to treat Fabry disease and the combination product, ATB200/AT2221, for treating Pompe disease. Additionally, in September 2020, Amicus Therapeutics, Inc. was granted PRIME designation for AT-GTX-501, therapy for CLN6 Batten disease.

Thus, the rapid regulatory approval with other marketing benefits for the drug with orphan drug designation is driving the market growth.

Based on enzyme type, the global enzyme replacement therapy market is segmented into alglucosidase alfa, agalsidase beta, imiglucerase, idursulfase, galsulfase, velaglucerase alfa, and other enzymes. In 2021, the other enzymes segment accounted for the largest market share. The same segment is expected to register the highest CAGR in the market from 2022 to 2028. Based on therapeutic conditions, the global enzyme replacement therapy market is segmented into Gaucher's disease, Fabry's disease, Pompe's disease, SCID, MPS, and other therapeutic conditions. The Gaucher's disease segment held the largest market share in 2021 and is expected to register the highest CAGR during the forecast period. Based on route of administration, the global enzyme replacement therapy market is bifurcated into parenteral and oral. The parenteral segment held a larger market share in 2021 and is anticipated to register a higher CAGR during the forecast period. Based on end user, the global enzyme replacement therapy market is segmented into hospitals, infusion centers, and others. The hospitals segment held the largest market share in 2021. However, the infusion centers segment is expected to register the highest CAGR during the forecast period.

Impact of COVID-19 Pandemic on Global Enzyme Replacement Therapy Market

The COVID-19 pandemic significantly affected the global healthcare system. To combat the spread of SAR-CoV-2 virus, governments imposed stringent policies to prevent and reduce the infection and mortality rates. According to the Department of Emergency Medicine, in many cities across various countries in North America, emergency department (ED) visits decreased by ~40% in 2020. Moreover, outpatient appointments and elective treatments were postponed or replaced by telemedicine practices.

Moreover, the interruption of ERT during the COVID-19 pandemic may have significant consequences. Due to restrictions on hospital visits during the pandemic, many scheduled ERTs were disrupted, which led to severity of conditions in LSDs patients. Also, lysosomal storage diseases are considered to be high risk because of respiratory, renal, and cardiac involvement. For instance, in 2021, a sample survey conducted by some doctors from Sir Ganga Ram Hospital, India, results of which were published in Indian Pediatrics, offered a glimpse into the crisis. The survey revealed that of the 26 patients suffering from lysosomal storage disorders and receiving ERT at the hospital, 20 (77%) had significant interruption in their treatment, with an average eight missed doses. Of the 20 patients who missed multiple doses, 13 (65%) could not collect the medicine from the tertiary care center due to lack of transportation as lockdown was in place, while for two (10%), the medicine import was delayed. Thus, such interruptions in ERT increased the suffering of LSDs patients and impacted the enzyme replacement therapy market negatively.

Various organic and inorganic strategies are adopted by companies operating in the global enzyme replacement therapy market. The organic strategies mainly include product launches and product approvals. Further, inorganic growth strategies witnessed in the market are acquisitions, collaborations, and partnerships. These growth strategies allow the market players to expand their businesses and enhance their geographic presence, thereby contributing to the overall market growth. Further, acquisition and partnership strategies help the market players in strengthening their customer base and expanding their product portfolios. A few of the significant developments by key players in the global enzyme replacement therapy market are listed below.

In May 2022, AbbVie and Cugene Inc., a clinical-stage biotechnology company focused on developing next-generation precision immunology and oncology medicines to treat autoimmune disease and cancer, announced an exclusive worldwide license option agreement for CUG252, a potential best-in-class Treg-selective IL-2 mutein, as well as other novel IL-2 muteins, for the potential treatment of autoimmune and inflammatory diseases.

In August 2021, the US Food and Drug Administration (FDA) approved Nexviazyme (avalglucosidase alfa-ngpt) for the treatment of patients aged one year and above suffering from late-onset Pompe disease, a progressive and debilitating muscle disorder that impairs a person's ability to move and breathe. Nexviazyme is an ERT designed to specifically target the mannose-6-phosphate (M6P) receptor, the key pathway for cellular uptake of ERT in Pompe disease. Nexviazyme has been shown in clinical trials to provide patients with improvements in respiratory function and walking distance.

A few major primary and secondary sources referred to while preparing the report on the global enzyme replacement therapy market are the National Health and Medical Research Council (NHMRC), the Government of Canada, and the Bioprocessing Technology Institute (BTI).

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the enzyme replacement therapy market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the enzyme replacement therapy market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhancing the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

1. Introduction

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 Global Enzyme Replacement Therapy Market - By Enzyme Type
- 1.3.2 Global Enzyme Replacement Therapy Market - By Therapeutic Conditions
- 1.3.3 Global Enzyme Replacement Therapy Market - By Route of Administration
- 1.3.4 Global Enzyme Replacement Therapy Market - By End User
- 1.3.5 Global Enzyme Replacement Therapy Market - By Geography

2. Enzyme Replacement Therapy Market- Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Global Enzyme Replacement Therapy Market - Market Landscape

4.1 Overview
4.2 PEST Analysis
- 4.2.1 North America - PEST Analysis
- 4.2.2 Europe - PEST Analysis
- 4.2.3 Asia Pacific - PEST Analysis
- 4.2.4 Middle East & Africa - PEST Analysis
- 4.2.5 South & Central America - PEST Analysis
4.3 Expert Opinion

5. Enzyme Replacement Therapy Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Rising Prevalence of Lysosomal Storage Diseases (LSDs)
- 5.1.2 Rapid Regulatory Approval with Other Benefits for Drug with Orphan Drug Designation
5.2 Market Restraints
- 5.2.1 Cutthroat Competition among Market Players
5.3 Market Opportunities
- 5.3.1 Increasing Partnerships and Collaborations to Synergize the Business
5.4 Future Trends
- 5.4.1 Innovative Developments in ERT
5.5 Impact Analysis

6. Enzyme Replacement Therapy Market- Global Analysis

6.1 Global Enzyme Replacement Therapy Market Revenue Forecast and Analysis
- 6.1.1 Global Enzyme Replacement Therapy Market Revenue Forecast and Analysis
- 6.1.2 Global Enzyme Replacement Therapy Market - Market Potential Analysis, By Region
6.2 Market Share Analysis of Key Players in Enzyme Replacement Therapy Market
- 6.2.1 Company Analysis
- 6.2.2 Growth Strategy Analysis
- 6.2.3 Performance of Key Players
  - 6.2.3.1 Sanofi S.A.
  - 6.2.3.2 BioMarin Pharmaceutical Inc.

7. Global Enzyme Replacement Therapy Market Revenue and Forecasts To 2028- by Enzyme Type

7.1 Overview
7.2 Global Enzyme Replacement Therapy Market, By Enzyme Type 2021 & 2028 (%)
7.3 Alglucosidase Alfa
- 7.3.1 Overview
- 7.3.2 Alglucosidase Alfa Revenue and Forecast to 2028 (US$ Million)
7.4 Agalsidase Beta
- 7.4.1 Overview
- 7.4.2 Agalsidase Beta - Revenue and Forecast to 2028 (US$ Million)
7.5 Imiglucerase
- 7.5.1 Overview
- 7.5.2 Imigluceras - Revenue and Forecast to 2028 (US$ Million)
7.6 Idursulfase
- 7.6.1 Overview
- 7.6.2 Idursulfase - Revenue and Forecast to 2028 (US$ Million)
7.7 Galsulfase
- 7.7.1 Overview
- 7.7.2 Galsulfase - Revenue and Forecast to 2028 (US$ Million)
7.8 Velaglucerase Alfa
- 7.8.1 Overview
- 7.8.2 Velaglucerase Alfa - Revenue and Forecast to 2028 (US$ Million)
7.9 Other Enzymes
- 7.9.1 Overview
- 7.9.2 Other Enzymes - Revenue and Forecast to 2028 (US$ Million)

8. Enzyme Replacement Therapy Market Analysis And Forecasts To 2028 - By Therapeutic Conditions

8.1 Overview
8.2 Global Enzyme Replacement Therapy Market, By Therapeutic Conditions 2021 & 2028 (%)
8.3 Gaucher's Disease
- 8.3.1 Overview
- 8.3.2 Gaucher's Disease - Market Revenue and Forecast to 2028 (US$ Million)
8.4 Fabry's Disease
- 8.4.1 Overview
- 8.4.2 Fabry's Disease - Market Revenue and Forecast to 2028 (US$ Million)
8.5 Mucopolysaccharidosis (MPS)
- 8.5.1 Overview
- 8.5.2 MPS - Market Revenue and Forecast to 2028 (US$ Million)
8.6 Pompe's Disease
- 8.6.1 Overview
- 8.6.2 Pompe's Disease - Market Revenue and Forecast to 2028 (US$ Million)
8.7 SCID
- 8.7.1 Overview
- 8.7.2 SCID - Market Revenue and Forecast to 2028 (US$ Million)
8.8 Other Therapeutic Conditions
- 8.8.1 Overview
- 8.8.2 Other Therapeutic Conditions - Market Revenue and Forecast to 2028 (US$ Million)

9. Enzyme Replacement Therapy Market Analysis And Forecasts To 2028 - By Route of Administration

9.1 Overview
9.2 Global Enzyme Replacement Therapy Market, By Route of Administration 2021 & 2028 (%)
9.3 Parenteral
- 9.3.1 Overview
- 9.3.2 Parenteral - Market Revenue and Forecast to 2028 (US$ Million)
9.4 Oral
- 9.4.1 Overview
- 9.4.2 Oral - Market Revenue and Forecast to 2028 (US$ Million)

10. Global Enzyme Replacement Therapy Market Analysis- By End User

10.1 Overview
10.2 Global Enzyme Replacement Therapy Market, By End User 2021 & 2028 (%)
10.3 Hospitals
- 10.3.1 Overview
- 10.3.2 Hospitals - Market Revenue And Forecasts To 2028 (US$ Million)
10.4 Infusion Centers
- 10.4.1 Overview
- 10.4.2 Infusion Centers - Market Revenue And Forecasts To 2028 (US$ Million)
10.5 Others
- 10.5.1 Overview
- 10.5.2 Others - Market Revenue And Forecasts To 2028 (US$ Million)

11. Enzyme Replacement Therapy Market Revenue and Forecasts to 2028 - Geographical Analysis

11.1 North America: Enzyme Replacement Therapy Market
- 11.1.1 Overview
- 11.1.2 North America: Enzyme Replacement Therapy Market - Revenue and Forecast to 2028 (US$ Million)
- 11.1.3 North America: Enzyme Replacement Therapy Market, by Enzyme Type, 2019-2028 (US$ Million)
- 11.1.4 North America: Enzyme Replacement Therapy Market, by Therapeutic Conditions, 2019-2028 (US$ Million)
- 11.1.5 North America: Enzyme Replacement Therapy Market, by Route of Administration, 2019-2028 (US$ Million)
- 11.1.6 North America: Enzyme Replacement Therapy Market, by End User, 2019-2028 (US$ Million)
- 11.1.7 North America: Enzyme Replacement Therapy Market, by Country, 2021 & 2028 (%)
  - 11.1.7.1 US: Enzyme Replacement Therapy Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.1.7.1.1 Overview
    - 11.1.7.1.2 US: Enzyme Replacement Therapy Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.1.7.1.3 US: Enzyme Replacement Therapy Market, by Enzyme Type, 2019-2028 (US$ Million)
    - 11.1.7.1.4 US: Enzyme Replacement Therapy Market, by Therapeutic Conditions, 2019-2028 (US$ Million)
    - 11.1.7.1.5 US: Enzyme Replacement Therapy Market, by Route of Administration, 2019-2028 (US$ Million)
    - 11.1.7.1.6 US: Enzyme Replacement Therapy Market, by End User, 2019-2028 (US$ Million)
  - 11.1.7.2 Canada: Enzyme Replacement Therapy Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.1.7.2.1 Overview
    - 11.1.7.2.2 Canada: Enzyme Replacement Therapy Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.1.7.2.3 Canada: Enzyme Replacement Therapy Market, by Enzyme Type, 2019-2028 (US$ Million)
    - 11.1.7.2.4 Canada: Enzyme Replacement Therapy Market, by Therapeutic Conditions, 2019-2028 (US$ Million)
    - 11.1.7.2.5 Canada: Enzyme Replacement Therapy Market, by Route of Administration, 2019-2028 (US$ Million)
    - 11.1.7.2.6 Canada: Enzyme Replacement Therapy Market, by End User, 2019-2028 (US$ Million)
  - 11.1.7.3 Mexico: Enzyme Replacement Therapy Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.1.7.3.1 Overview
    - 11.1.7.3.2 Mexico: Enzyme Replacement Therapy Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.1.7.3.3 Mexico: Enzyme Replacement Therapy Market, by Enzyme Type, 2019-2028 (US$ Million)
    - 11.1.7.3.4 Mexico: Enzyme Replacement Therapy Market, by Therapeutic Conditions, 2019-2028 (US$ Million)
    - 11.1.7.3.5 Mexico: Enzyme Replacement Therapy Market, by Route of Administration, 2019-2028 (US$ Million)
    - 11.1.7.3.6 Mexico: Enzyme Replacement Therapy Market, by End User, 2019-2028 (US$ Million)
11.2 Europe: Enzyme Replacement Therapy Market
- 11.2.1 Overview
- 11.2.2 Europe: Enzyme Replacement Therapy Market - Revenue and Forecast to 2028 (US$ Million)
- 11.2.3 Europe: Enzyme Replacement Therapy Market, by Enzyme Type, 2019-2028 (US$ Million)
- 11.2.4 Europe: Enzyme Replacement Therapy Market, by Therapeutic Conditions, 2019-2028 (US$ Million)
- 11.2.5 Europe: Enzyme Replacement Therapy Market, by Route of Administration, 2019-2028 (US$ Million)
- 11.2.6 Europe: Enzyme Replacement Therapy Market, by End User, 2019-2028 (US$ Million)
- 11.2.7 Europe: Enzyme Replacement Therapy Market, by Country, 2021 & 2028 (%)
  - 11.2.7.1 Germany: Enzyme Replacement Therapy Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.2.7.1.1 Overview
    - 11.2.7.1.2 Germany: Enzyme Replacement Therapy Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.2.7.1.3 Germany: Enzyme Replacement Therapy Market, by Enzyme Type, 2019-2028 (US$ Million)
    - 11.2.7.1.4 Germany: Enzyme Replacement Therapy Market, by Therapeutic Conditions, 2019-2028 (US$ Million)
    - 11.2.7.1.5 Germany: Enzyme Replacement Therapy Market, by Route of Administration, 2019-2028 (US$ Million)
    - 11.2.7.1.6 Germany: Enzyme Replacement Therapy Market, by End User, 2019-2028 (US$ Million)
  - 11.2.7.2 UK: Enzyme Replacement Therapy Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.2.7.2.1 Overview
    - 11.2.7.2.2 UK: Enzyme Replacement Therapy Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.2.7.2.3 UK: Enzyme Replacement Therapy Market, by Enzyme Type, 2019-2028 (US$ Million)
    - 11.2.7.2.4 UK: Enzyme Replacement Therapy Market, by Therapeutic Conditions, 2019-2028 (US$ Million)
    - 11.2.7.2.5 UK: Enzyme Replacement Therapy Market, by Route of Administration, 2019-2028 (US$ Million)
    - 11.2.7.2.6 UK: Enzyme Replacement Therapy Market, by End User, 2019-2028 (US$ Million)
  - 11.2.7.3 France: Enzyme Replacement Therapy Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.2.7.3.1 Overview
    - 11.2.7.3.2 France: Enzyme Replacement Therapy Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.2.7.3.3 France: Enzyme Replacement Therapy Market, by Enzyme Type, 2019-2028 (US$ Million)
    - 11.2.7.3.4 France: Enzyme Replacement Therapy Market, by Therapeutic Conditions, 2019-2028 (US$ Million)
    - 11.2.7.3.5 France: Enzyme Replacement Therapy Market, by Route of Administration, 2019-2028 (US$ Million)
    - 11.2.7.3.6 France: Enzyme Replacement Therapy Market, by End User, 2019-2028 (US$ Million)
  - 11.2.7.4 Italy: Enzyme Replacement Therapy Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.2.7.4.1 Overview
    - 11.2.7.4.2 Italy: Enzyme Replacement Therapy Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.2.7.4.3 Italy: Enzyme Replacement Therapy Market, by Enzyme Type, 2019-2028 (US$ Million)
    - 11.2.7.4.4 Italy: Enzyme Replacem4ent Therapy Market, by Therapeutic Conditions, 2019-2028 (US$ Million)
    - 11.2.7.4.5 Italy: Enzyme Replacement Therapy Market, by Route of Administration, 2019-2028 (US$ Million)
    - 11.2.7.4.6 Italy: Enzyme Replacement Therapy Market, by End User, 2019-2028 (US$ Million)
  - 11.2.7.5 Spain: Enzyme Replacement Therapy Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.2.7.5.1 Overview
    - 11.2.7.5.2 Spain: Enzyme Replacement Therapy Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.2.7.5.3 Spain: Enzyme Replacement Therapy Market, by Enzyme Type, 2019-2028 (US$ Million)
    - 11.2.7.5.4 Spain: Enzyme Replacement Therapy Market, by Therapeutic Conditions, 2019-2028 (US$ Million)
    - 11.2.7.5.5 Spain: Enzyme Replacement Therapy Market, by Route of Administration, 2019-2028 (US$ Million)
    - 11.2.7.5.6 Spain: Enzyme Replacement Therapy Market, by End User, 2019-2028 (US$ Million)
  - 11.2.7.6 Rest of Europe: Enzyme Replacement Therapy Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.2.7.6.1 Overview
    - 11.2.7.6.2 Rest of Europe: Enzyme Replacement Therapy Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.2.7.6.3 Rest of Europe: Enzyme Replacement Therapy Market, by Enzyme Type, 2019-2028 (US$ Million)
    - 11.2.7.6.4 Rest of Europe: Enzyme Replacement Therapy Market, by Therapeutic Conditions, 2019-2028 (US$ Million)
    - 11.2.7.6.5 Rest of Europe: Enzyme Replacement Therapy Market, by Route of Administration, 2019-2028 (US$ Million)
    - 11.2.7.6.6 Rest of Europe: Enzyme Replacement Therapy Market, by End User, 2019-2028 (US$ Million)
11.3 Asia Pacific: Enzyme Replacement Therapy Market Revenue and Forecasts To 2028
- 11.3.1 Overview
- 11.3.2 Asia Pacific: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028 (US$ Million)
- 11.3.3 Asia Pacific: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Enzyme Type (US$ Million)
- 11.3.4 Asia Pacific: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Therapeutic Conditions (US$ Million)
- 11.3.5 Asia Pacific: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
- 11.3.6 Asia Pacific: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By End User (US$ Million)
- 11.3.7 Asia Pacific: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Country (%)
  - 11.3.7.1 Japan: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028 (US$ Million)
    - 11.3.7.1.1 Overview
    - 11.3.7.1.2 Japan: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028 (US$ Million)
    - 11.3.7.1.3 Japan: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Enzyme Type (US$ Million)
    - 11.3.7.1.4 Japan: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Therapeutic Conditions (US$ Million)
    - 11.3.7.1.5 Japan: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
    - 11.3.7.1.6 Japan: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By End User (US$ Million)
  - 11.3.7.2 China: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028 (US$ Million)
    - 11.3.7.2.1 Overview
    - 11.3.7.2.2 China: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028 (US$ Million)
    - 11.3.7.2.3 China: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Enzyme Type (US$ Million)
    - 11.3.7.2.4 China: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Therapeutic Conditions (US$ Million)
    - 11.3.7.2.5 China: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
    - 11.3.7.2.6 China: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By End User (US$ Million)
  - 11.3.7.3 India Enzyme Replacement Therapy Market Revenue and Forecasts to 2028 (US$ Million)
    - 11.3.7.3.1 Overview
    - 11.3.7.3.2 India: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028 (US$ Million)
    - 11.3.7.3.3 India: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Enzyme Type (US$ Million)
    - 11.3.7.3.4 India: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Therapeutic Conditions (US$ Million)
    - 11.3.7.3.5 India: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
    - 11.3.7.3.6 India: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By End User (US$ Million)
  - 11.3.7.4 Australia: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028 (US$ Million)
    - 11.3.7.4.1 Overview
    - 11.3.7.4.2 Australia: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028 (US$ Million)
    - 11.3.7.4.3 Australia: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Enzyme Type (US$ Million)
    - 11.3.7.4.4 Australia: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Therapeutic Conditions (US$ Million)
    - 11.3.7.4.5 Australia: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
    - 11.3.7.4.6 Australia: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By End User (US$ Million)
  - 11.3.7.5 South Korea: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028 (US$ Million)
    - 11.3.7.5.1 Overview
    - 11.3.7.5.2 South Korea: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028 (US$ Million)
    - 11.3.7.5.3 South Korea: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Enzyme Type (US$ Million)
    - 11.3.7.5.4 South Korea: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Therapeutic Conditions (US$ Million)
    - 11.3.7.5.5 South Korea: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
    - 11.3.7.5.6 South Korea: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By End User (US$ Million)
  - 11.3.7.6 Rest of Asia Pacific: Enzyme Replacement Therapy Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.3.7.6.1 Overview
    - 11.3.7.6.2 Rest of Asia Pacific: Enzyme Replacement Therapy Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.3.7.6.3 Rest of Asia Pacific: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Enzyme Type (US$ Million)
    - 11.3.7.6.4 Rest of Asia Pacific: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Therapeutic Conditions (US$ Million)
    - 11.3.7.6.5 Rest of Asia Pacific: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
    - 11.3.7.6.6 Rest of Asia Pacific: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By End User (US$ Million)
11.4 South & Central America: Enzyme Replacement Therapy Market
- 11.4.1 Overview
- 11.4.2 South and Central America: Enzyme Replacement Therapy Market - Revenue and Forecast to 2028 (USD Million)
- 11.4.3 South and Central America: Enzyme Replacement Therapy Market, by Enzyme Type, 2019-2028 (USD Million)
- 11.4.4 South and Central America: Enzyme Replacement Therapy Market, by Therapeutic Conditions, 2019-2028 (USD Million)
- 11.4.5 South and Central America: Enzyme Replacement Therapy Market, by Route of Administration, 2019-2028 (USD Million)
- 11.4.6 South and Central America: Enzyme Replacement Therapy Market, by End User, 2019-2028 (USD Million)
- 11.4.7 South and Central America: Enzyme Replacement Therapy Market, by country, 2021 & 2028 (%)
  - 11.4.7.1 Brazil: Enzyme Replacement Therapy Market - Revenue and Forecast to 2028 (USD Million)
    - 11.4.7.1.1 Brazil: Enzyme Replacement Therapy Market - Revenue and Forecast to 2028 (USD Million)
    - 11.4.7.1.2 Brazil: Enzyme Replacement Therapy Market, by Enzyme Type, 2019-2028 (USD Million)
    - 11.4.7.1.3 Brazil: Enzyme Replacement Therapy Market, by Therapeutic Conditions, 2019-2028 (USD Million)
    - 11.4.7.1.4 Brazil: Enzyme Replacement Therapy Market, by Route of Administration, 2019-2028 (USD Million)
    - 11.4.7.1.5 Brazil: Enzyme Replacement Therapy Market, by End User, 2019-2028 (USD Million)
  - 11.4.7.2 Argentina: Enzyme Replacement Therapy Market - Revenue and Forecast to 2028 (USD Million)
    - 11.4.7.2.1 Argentina: Enzyme Replacement Therapy Market - Revenue and Forecast to 2028 (USD Million)
    - 11.4.7.2.2 Argentina: Enzyme Replacement Therapy Market, by Enzyme Type, 2019-2028 (USD Million)
    - 11.4.7.2.3 Argentina: Enzyme Replacement Therapy Market, by Therapeutic Conditions, 2019-2028 (USD Million)
    - 11.4.7.2.4 Argentina: Enzyme Replacement Therapy Market, by Route of Administration, 2019-2028 (USD Million)
    - 11.4.7.2.5 Argentina: Enzyme Replacement Therapy Market, by End User, 2019-2028 (USD Million)
  - 11.4.7.3 Rest of South and Central America: Enzyme Replacement Therapy Market - Revenue and Forecast to 2028 (USD Million)
    - 11.4.7.3.1 Rest of South and Central America: Enzyme Replacement Therapy Market - Revenue and Forecast to 2028 (USD Million)
    - 11.4.7.3.2 Rest of South and Central America: Enzyme Replacement Therapy Market, by Enzyme Type, 2019-2028 (USD Million)
    - 11.4.7.3.3 Rest of South and Central America: Enzyme Replacement Therapy Market, by Therapeutic Conditions, 2019-2028 (USD Million)
    - 11.4.7.3.4 Rest of South and Central America: Enzyme Replacement Therapy Market, by Route of Administration, 2019-2028 (USD Million)
    - 11.4.7.3.5 Rest of South and Central America: Enzyme Replacement Therapy Market, by End User, 2019-2028 (USD Million)
11.5 Middle East & Africa Enzyme Replacement Therapy Market
- 11.5.1 Overview
- 11.5.2 Middle East & Africa: Enzyme Replacement Therapy Market Revenue and Forecast to 2028 (US$ Million)
- 11.5.3 Middle East & Africa: Enzyme Replacement Therapy Market Revenue and Forecast to 2028, by Enzyme Type (US$ Million)
- 11.5.4 Middle East & Africa: Enzyme Replacement Therapy Market Revenue and Forecast to 2028, by Therapeutic Conditions (US$ Million)
- 11.5.5 Middle East & Africa: Enzyme Replacement Therapy Market Revenue and Forecast to 2028, by Route of Administration (US$ Million)
- 11.5.6 Middle East & Africa: Enzyme Replacement Therapy Market Revenue and Forecast to 2028, by End User (US$ Million)
- 11.5.7 Middle East & Africa Enzyme Replacement Therapy Market Revenue and Forecast to 2028, by Country (%)
  - 11.5.7.1 Saudi Arabia: Enzyme Replacement Therapy Market - Revenue and Forecast to 2028 (USD Million)
    - 11.5.7.1.1 Overview
    - 11.5.7.1.2 Saudi Arabia Enzyme Replacement Therapy Market Revenue and Forecast to 2028 (US$ Million)
    - 11.5.7.1.3 Saudi Arabia: Enzyme Replacement Therapy Market Revenue and Forecast to 2028, By Enzyme Type (US$ Million)
    - 11.5.7.1.4 Saudi Arabia: Enzyme Replacement Therapy Market Revenue and Forecast To 2028, By Therapeutic Conditions (US$ Million)
    - 11.5.7.1.5 Saudi Arabia: Enzyme Replacement Therapy Market Revenue and Forecast to 2028, By Route of Administration (US$ Million)
    - 11.5.7.1.6 Saudi Arabia: Enzyme Replacement Therapy Market Revenue and Forecast To 2028, By End User (US$ Million)
  - 11.5.7.2 South Africa: Enzyme Replacement Therapy Market - Revenue and Forecast to 2028 (USD Million)
    - 11.5.7.2.1 Overview
    - 11.5.7.2.2 South Africa Enzyme Replacement Therapy Market Revenue and Forecast to 2028 (US$ Million)
    - 11.5.7.2.3 South Africa: Enzyme Replacement Therapy Market Revenue and Forecast to 2028, By Enzyme Type (US$ Million)
    - 11.5.7.2.4 South Africa: Enzyme Replacement Therapy Market Revenue and Forecast To 2028, By Therapeutic Conditions (US$ Million)
    - 11.5.7.2.5 South Africa: Enzyme Replacement Therapy Market Revenue and Forecast To 2028, By Route of Administration (US$ Million)
    - 11.5.7.2.6 South Africa: Enzyme Replacement Therapy Market Revenue and Forecast To 2028, By End User (US$ Million)
  - 11.5.7.3 UAE: Enzyme Replacement Therapy Market - Revenue and Forecast to 2028 (USD Million)
    - 11.5.7.3.1 Overview
    - 11.5.7.3.2 UAE: Enzyme Replacement Therapy Market Revenue and Forecast to 2028 (US$ Million)
    - 11.5.7.3.3 UAE: Enzyme Replacement Therapy Market Revenue and Forecast to 2028, By Enzyme Type (US$ Million)
    - 11.5.7.3.4 UAE: Enzyme Replacement Therapy Market Revenue and Forecast To 2028, By Therapeutic Conditions (US$ Million)
    - 11.5.7.3.5 UAE: Enzyme Replacement Therapy Market Revenue and Forecast To 2028, By Route of Administration (US$ Million)
    - 11.5.7.3.6 UAE: Enzyme Replacement Therapy Market Revenue and Forecast To 2028, By End User (US$ Million)
  - 11.5.7.4 Rest of the Middle East and Africa: Enzyme Replacement Therapy Market - Revenue and Forecast to 2028 (USD Million)
    - 11.5.7.4.1 Overview
    - 11.5.7.4.2 Rest of the Middle East and Africa Enzyme Replacement Therapy Market Revenue and Forecast to 2028 (US$ Million)
    - 11.5.7.4.3 Rest of the Middle East and Africa: Enzyme Replacement Therapy Market Revenue and Forecast to 2028, By Enzyme Type (US$ Million)
    - 11.5.7.4.4 Rest of the Middle East and Africa: Enzyme Replacement Therapy Market Revenue and Forecast To 2028, By Therapeutic Conditions (US$ Million)
    - 11.5.7.4.5 Rest of the Middle East and Africa: Enzyme Replacement Therapy Market Revenue and Forecast To 2028, By Route of Administration (US$ Million)
    - 11.5.7.4.6 Rest of the Middle East and Africa: Enzyme Replacement Therapy Market Revenue and Forecast To 2028, By End User (US$ Million)

12. Impact Of COVID-19 Pandemic on Enzyme Replacement Therapy Market

12.1 North America: Impact Assessment of COVID-19 Pandemic
12.2 Europe: Impact Assessment of COVID-19 Pandemic
12.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
12.4 South and Central America: Impact Assessment of COVID-19 Pandemic
12.5 Middle East and Africa: Impact Assessment of COVID-19 Pandemic

13. Enzyme Replacement Therapy Market-Industry Landscape

13.1 Overview
13.2 Growth Strategies in the Enzyme Replacement Therapy Market
13.3 Inorganic Growth Strategies
- 13.3.1 Overview
13.4 Organic Growth Strategies
- 13.4.1 Overview

14. Company Profiles

14.1 Takeda Pharmaceutical Company Limited
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 inancial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Sanofi
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 AbbVie Inc.
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 BioMarin Pharmaceutical Inc.
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 Amicus Therapeutics
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 Alexion Pharmaceuticals, Inc.(AstraZeneca)
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 WOT Analysis
- 14.6.6 Key Developments
14.7 Janssen Pharmaceuticals (Johnson & Johnson Services, Inc.)
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 Recordati S.p.A.
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
14.9 Pfizer Inc.
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
14.10 CHIESI Farmaceutici S.p.A.
- 14.10.1 Key Facts
- 14.10.2 Business Description
- 14.10.3 Products and Services
- 14.10.4 Financial Overview
- 14.10.5 SWOT Analysis
- 14.10.6 Key Developments

15. Appendix

15.1 About The Insight Partners
15.2 Glossary of Terms

酵素補充療法市場の2028年までの予測-酵素タイプ、治療条件、投与経路、エンドユーザー別の世界分析

Enzyme Replacement Therapy Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Enzyme Type, Therapeutic Conditions, Route of Administration, and End User

目次

第1章イントロダクション

第2章酵素補充療法市場-主要なポイント

第3章調査手法

第4章酵素補充療法の世界市場-市場情勢

第5章酵素補充療法市場- 主な市場力学

第6章酵素補充療法市場-世界分析

第7章酵素補充療法の世界市場収益と2028年までの予測-酵素タイプ別

第8章酵素補充療法市場の分析と2028年までの予測-治療条件別

第9章酵素補充療法市場の分析と2028年までの予測-投与経路別

第10章酵素補充療法の世界市場分析-エンドユーザー別

第11章酵素補充療法市場の収益と2028年までの予測- 地域別分析

第12章酵素補充療法市場へのCOVID-19パンデミックの影響

第13章酵素補充療法市場-業界情勢

第14章企業プロファイル

第15章付録

List Of Tables

List Of Figures

Reasons to Buy:

Table Of Contents

1. Introduction

2. Enzyme Replacement Therapy Market- Key Takeaways

3. Research Methodology

4. Global Enzyme Replacement Therapy Market - Market Landscape

5. Enzyme Replacement Therapy Market - Key Market Dynamics

6. Enzyme Replacement Therapy Market- Global Analysis

7. Global Enzyme Replacement Therapy Market Revenue and Forecasts To 2028- by Enzyme Type

8. Enzyme Replacement Therapy Market Analysis And Forecasts To 2028 - By Therapeutic Conditions

9. Enzyme Replacement Therapy Market Analysis And Forecasts To 2028 - By Route of Administration

10. Global Enzyme Replacement Therapy Market Analysis- By End User

11. Enzyme Replacement Therapy Market Revenue and Forecasts to 2028 - Geographical Analysis

12. Impact Of COVID-19 Pandemic on Enzyme Replacement Therapy Market

13. Enzyme Replacement Therapy Market-Industry Landscape

14. Company Profiles

15. Appendix

酵素補充療法市場の2028年までの予測-酵素タイプ、治療条件、投与経路、エンドユーザー別の世界分析

Enzyme Replacement Therapy Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Enzyme Type, Therapeutic Conditions, Route of Administration, and End User

目次

第1章 イントロダクション

第2章 酵素補充療法市場-主要なポイント

第3章 調査手法

第4章 酵素補充療法の世界市場-市場情勢

第5章 酵素補充療法市場- 主な市場力学

第6章 酵素補充療法市場-世界分析

第7章 酵素補充療法の世界市場収益と2028年までの予測-酵素タイプ別

第8章 酵素補充療法市場の分析と2028年までの予測-治療条件別

第9章 酵素補充療法市場の分析と2028年までの予測-投与経路別

第10章 酵素補充療法の世界市場分析-エンドユーザー別

第11章 酵素補充療法市場の収益と2028年までの予測- 地域別分析

第12章 酵素補充療法市場へのCOVID-19パンデミックの影響

第13章 酵素補充療法市場-業界情勢

第14章 企業プロファイル

第15章 付録

List Of Tables

List Of Figures

Reasons to Buy:

Table Of Contents

1. Introduction

2. Enzyme Replacement Therapy Market- Key Takeaways

3. Research Methodology

4. Global Enzyme Replacement Therapy Market - Market Landscape

5. Enzyme Replacement Therapy Market - Key Market Dynamics

6. Enzyme Replacement Therapy Market- Global Analysis

7. Global Enzyme Replacement Therapy Market Revenue and Forecasts To 2028- by Enzyme Type

8. Enzyme Replacement Therapy Market Analysis And Forecasts To 2028 - By Therapeutic Conditions

9. Enzyme Replacement Therapy Market Analysis And Forecasts To 2028 - By Route of Administration

10. Global Enzyme Replacement Therapy Market Analysis- By End User

11. Enzyme Replacement Therapy Market Revenue and Forecasts to 2028 - Geographical Analysis

12. Impact Of COVID-19 Pandemic on Enzyme Replacement Therapy Market

13. Enzyme Replacement Therapy Market-Industry Landscape

14. Company Profiles

15. Appendix

第1章イントロダクション

第2章酵素補充療法市場-主要なポイント

第3章調査手法

第4章酵素補充療法の世界市場-市場情勢

第5章酵素補充療法市場- 主な市場力学

第6章酵素補充療法市場-世界分析

第7章酵素補充療法の世界市場収益と2028年までの予測-酵素タイプ別

第8章酵素補充療法市場の分析と2028年までの予測-治療条件別

第9章酵素補充療法市場の分析と2028年までの予測-投与経路別

第10章酵素補充療法の世界市場分析-エンドユーザー別

第11章酵素補充療法市場の収益と2028年までの予測- 地域別分析

第12章酵素補充療法市場へのCOVID-19パンデミックの影響

第13章酵素補充療法市場-業界情勢

第14章企業プロファイル

第15章付録